🇺🇸 FDA

Company profile · Sponsor

Biotech

Biotech Pharmaceutical Co.,

C06D38C · NMPA biotech CN
Pipeline
24
Drugs
0
Patents
0

Quick answer

Biotech (C06D38C) is a biotech company. headquartered in CN. listed on NMPA. NovaPharmaNews links 24 pipeline programs, 0 drugs, and 0 patents to this profile..

Company facts

Ticker C06D38C
Exchange NMPA
Company type biotech
Headquarters CN

Pipeline (24)

Search pipeline →

  1. Faceptor

    Biotech

    Breast Cancer Metastatic

    phase 3 small molecule completed

    2 trials

  2. Nanocovax

    Biotech

    SARS-CoV-2 Infection

    phase 3 mab completed

    1 trial

  3. Olorofim

    Biotech

    Invasive Aspergillosis

    phase 3 small molecule active

    1 trial

  4. Participants will receive one dose of vaccine (0.5 mL) of Sinovac QIV

    Biotech

    Influenza

    phase 3 mab active

    1 trial

  5. Recombinant Human VEGF Receptor-Fc Fusion Protein

    Biotech

    Neovascular Age-related Macular Degeneration

    phase 3 mab completed

    1 trial

  6. SARS-CoV-2 mRNA Vaccine

    Biotech

    COVID-19

    phase 3 mab active

    1 trial

  7. Stimus (NNG-DEPO)

    Biotech

    Anemia

    phase 3 mab completed

    1 trial

  8. Walvax PCV13-TT

    Biotech

    Pneumococcal Disease, Invasive

    phase 3 mab active

    1 trial

  9. eN-Lac®

    Biotech

    Perennial Allergic Rhinitis

    phase 3 mab completed

    1 trial

  10. pegcyte

    Biotech

    Breast Cancer Female

    phase 3 small molecule completed

    1 trial

  11. COVAXIN(BBV152)

    Biotech

    Corona Virus Infection

    phase 2 mab completed

    1 trial

  12. Chidamide

    Biotech

    Relapsed or Refractory Peripheral T-cell Lymphoma

    phase 2 small molecule active

    1 trial

  13. Chidamide

    Biotech

    Hepatocellular Carcinoma (HCC)

    phase 2 small molecule terminated

    1 trial

  14. EPI-321

    Biotech

    Facioscapulohumeral Muscular Dystrophy

    phase 2 mab active

    1 trial

  15. Laminectomy

    Biotech

    Acute Spinal Cord Injury

    phase 2 other active

    1 trial

  16. Olorofim

    Biotech

    Invasive Fungal Infections

    phase 2 small molecule completed

    1 trial

  17. PI-88

    Biotech

    Lung Cancer

    phase 2 small molecule completed

    1 trial

  18. Placebo

    Biotech

    Hemophilic Arthropathy

    phase 2 small molecule completed

    1 trial

  19. SCB01A

    Biotech

    Head and Neck Neoplasms

    phase 2 small molecule terminated

    1 trial

  20. SHJ002/Vehicle

    Biotech

    Dry Eye Disease

    phase 2 small molecule completed

    1 trial

  21. SR-T100 ® Gel

    Biotech

    Actinic Keratosis

    phase 2 small molecule completed

    1 trial

  22. TG-873870 (Nemonoxacin)

    Biotech

    Diabetic Foot Infections

    phase 2 small molecule completed

    1 trial

  23. CD19-TriCAR-T/SILK

    Biotech

    Non-Hodgkin Lymphoma

    phase 1 mab active

    1 trial

  24. LBT-3627

    Biotech

    Parkinson Disease

    phase 1 small molecule active

    1 trial

Frequently asked questions

What is Biotech?

Biotech (C06D38C) is a biotech company. headquartered in CN. listed on NMPA. NovaPharmaNews links 24 pipeline programs, 0 drugs, and 0 patents to this profile..

What pipeline programs does Biotech sponsor?

We track 24 ClinicalTrials.gov-linked programs for Biotech, including Faceptor and 23 more. Open each program for phase, modality, NCT IDs, and indication details.

Where does Biotech company data come from?

Profiles combine SEC EDGAR (CIK/ticker), ClinicalTrials.gov sponsor links, FDA drug records, and USPTO patent metadata. See our data sources page. This profile is for professional reference, not investment advice.